Feedback / Questions
KG006 - Celltrion
KG002 - Celltrion
https://www.prnewswire.com/news-releases/kaigene-enters-into-exclusive-licensing-agreement-with-celltrion-for-novel-antibody-therapeutics-in-autoimmune-diseases-302602595.html
 
Nov 3, 2025
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious